[1]
Patel, I. et al. 2021. Eculizumab as a Treatment for Hyper-Haemolytic and Aplastic Crisis in Sickle Cell Disease. European Journal of Case Reports in Internal Medicine. 8, 10 (Oct. 2021). DOI:https://doi.org/10.12890/2021_002824.